Skip to main content
FDMT
NASDAQ Life Sciences

Wiseek Filing Insight

Analysis by Wiseek.ai
Sentiment info
Neutral
Importance info
4
Price
$9.42
Mkt Cap
$480.905M
52W Low
$3
52W High
$12.34
Market data snapshot near publication time

check_boxKey Events

  • No key events were highlighted for this filing.

auto_awesomeAnalysis

No analysis available.

At the time of this filing, FDMT was trading at $9.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $480.9M. The 52-week trading range was $3.00 to $12.34. This filing was assessed with an importance score of 4 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed FDMT - Latest Insights

FDMT
Apr 28, 2026, 4:05 PM EDT
Filing Type: DEF 14A
Importance Score:
7
4D Molecular Therapeutics Details Executive Changes, Related-Party Deal, and Significant Potential Dilution in Proxy Filing
Sentiment: Negative
View Wiseek Article
FDMT
Mar 18, 2026, 4:29 PM EDT
Filing Type: 10-K
Importance Score:
9
4D Molecular Therapeutics Secures Major Otsuka Partnership, Advances Key Clinical Programs, and Reports Strong 2025 Financials
Sentiment: Positive
View Wiseek Article
FDMT
Mar 18, 2026, 4:09 PM EDT
Filing Type: 8-K
Importance Score:
9
4DMT Reports Strong 2025 Results, Major Otsuka Partnership, Extended Cash Runway, and Clinical Progress
Sentiment: Positive
View Wiseek Article
FDMT
Mar 18, 2026, 4:05 PM EDT
Source: GlobeNewswire
Importance Score:
9
Otsuka Partnership Brings $85M Upfront, 4DMT Raises $118M, Extends Cash Runway to H2 2028
Sentiment: Positive
View Wiseek Article
FDMT
Jan 26, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
4D Molecular Therapeutics Restructures Major Investor Holdings via Warrant Exchange
Sentiment: Neutral
View Wiseek Article
FDMT
Jan 07, 2026, 8:05 AM EST
Filing Type: 8-K
Importance Score:
8
4D Molecular Therapeutics Reports $514M Cash, Exceeding Market Cap; Announces Leadership Changes
Sentiment: Positive
View Wiseek Article